Lymphocytopenia. D72.810 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM D72.810 became effective on October 1, 2020. This is the American ICD-10-CM version of D72.810 - other international versions of ICD-10 D72.810 may differ.
Leukopenia D72.819 ICD-10-CM Diagnosis Code D72.819 Decreased white blood cell count, unspecified 2016 2017 2018 2019 2020 2021 Billable/Specific Code Applicable To Decreased leukocytes, unspecified Leukocytopenia, unspecified Leukopenia Type 1 Excludes malignant leukopenia ( D70.9) basophilic D72.818. ICD-10-CM Diagnosis Code D72.818.
Agranulocytosis secondary to cancer chemotherapy. D70.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM D70.1 became effective on October 1, 2018. This is the American ICD-10-CM version of D70.1 - other international versions of ICD-10 D70.1 may differ.
Agranulocytosis secondary to cancer chemotherapy 1 D70.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM D70.1 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of D70.1 - other international versions of ICD-10 D70.1 may differ.
D72.819ICD-10 Code for Decreased white blood cell count, unspecified- D72. 819- Codify by AAPC.
D84. 821 Immunodeficiency due to drugs Medications that interfere with the immune system. These medications include immunosuppressants, corticosteroids, and chemotherapy.
1 for Encounter for antineoplastic chemotherapy and immunotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10-CM Code for Antineoplastic chemotherapy induced pancytopenia D61. 810.
ICD-10 code D84. 81 for Immunodeficiency due to conditions classified elsewhere is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
ICD-10-CM Code for Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter T45. 1X5A.
ICD-10 Code for Other long term (current) drug therapy- Z79. 899- Codify by AAPC.
ICD-10 Codes for Long-term TherapiesCodeLong-term (current) use ofZ79.84oral hypoglycemic drugsZ79.891opiate analgesicZ79.899other drug therapy21 more rows•Aug 15, 2017
Z85. 3 can be billed as a primary diagnosis if that is the reason for the visit, but follow up after completed treatment for cancer should coded as Z08 as the primary diagnosis.
D70. 1 - Agranulocytosis secondary to cancer chemotherapy | ICD-10-CM.
There are a number of different conditions that can cause pancytopenia, including bone marrow diseases, some cancers, and some infections; chemotherapy treatment can also cause pancytopenia.
9: Fever, unspecified.
Assign code V58. 11, Encounter for antineoplastic chemotherapy, as the principal diagnosis if a patient is admitted solely for chemotherapy administration.
Code 96413 (chemotherapy administration, intravenous infusion technique; up to one hour, single or initial substance/drug) would be used to report the first 90 minutes of the infusion.
The 2022 edition of ICD-10-CM D72.819 became effective on October 1, 2021.
neutropenia ( D70.-) A condition in which there is a lower-than-normal number of leukocytes (white blood cells) in the blood. A finding based on laboratory test results that indicate an decrease in number of white blood cells in a blood specimen.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
The 2022 edition of ICD-10-CM D70.1 became effective on October 1, 2021.
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code ( D61.810) and the excluded code together.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
The 2022 edition of ICD-10-CM D61.810 became effective on October 1, 2021.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
The 2022 edition of ICD-10-CM D70.2 became effective on October 1, 2021.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
The 2022 edition of ICD-10-CM T45.1X5A became effective on October 1, 2021.
T45- Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
The 2022 edition of ICD-10-CM D72.810 became effective on October 1, 2021.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
neutropenia ( D70.-) A condition in which there is a lower-than-normal number of lymphocytes (a type of white blood cell) in the blood. A finding based on laboratory test results that indicate a decrease in number of lymphocytes in a blood specimen. An abnormally small number of lymphocytes in the circulating blood.